KIRT POSS
Executive Partner - Life Science
Kirt Poss is an Executive Partner with Edgewater Capital Partners in the Life Science practice. Mr. Poss brings more than 25 years of CEO healthcare leadership and business growth experience to Edgewater. Most recently, he served as CEO-US of ProtaGene, a leading provider of advanced analytics in biopharmaceutical platform development, which was formed in a PE-backed M&A in 2021. Previously, he founded and served as CEO of BioAnalytix, where he led the company from early commercial growth through M&A with Protagen Protein Services in 2019. Before founding BioAnalytix, Mr. Poss co-founded and served as CEO of the biomarker imaging company VisEn Medical from its early product development through worldwide commercialization and M&A with PerkinElmer in 2010. Before that, Mr. Poss worked in healthcare business strategy consulting in Cambridge, MA, where he focused in the pharmaceutical and medical device sectors. Earlier in his career, Mr. Poss worked in scientific research at the Center for Molecular Imaging Research at the MGH and Harvard Medical School. Before transitioning into science, Mr. Poss earned a BA in Political Science and English from the University of Connecticut.